Medical devices are playing an increasingly important role in diabetes. Products such as blood glucose monitors and insulin pumps have now become the cornerstone for the management of blood glucose levels. At the moment, more invasive devices are being increasingly used in diabetes, such as those used in bariatric surgery. While such products continue to dominate the diabetes care devices market, there is a growing interest in innovative new technologies, such as non-invasive blood glucose monitoring and continuous glucose monitoring; which can offer regular blood glucose measurements (typically every few minutes). This is particularly useful as it provides greater insight into glucose levels throughout the day.
With technology continuing to advance and the prevalence of diabetes on the rise, the blood glucose monitoring market is set for major expansion in the next decade.
Forecasts in that Study – Overall World Market, Submarket, Product and Country For the purpose of this report, the focus is self-monitoring blood glucose (SMBG) devices. The market size and forecast presented in the report are for SMBG devices. This report provides an overview of the SMBG devices market with a discussion of its segments, especially those that contribute to the development of the industry.
The report will focus on the four main segments of the market: • Glucose Test Strips • Glucose Meters • Continuous Glucose Monitoring • Accessories
Our work also shows individual revenue forecasts to 2026 for 12 national markets: • United States (US) • Japan • EU leaders – Germany, France, the UK, Italy and Spain (EU5) • BRIC nations – Brazil, Russia, India and China • Rest of the World (RoW)
Why Should You Read This Report This comprehensive report will: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to utilize • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximise profitability for your company.
How This Report Delivers This 165 page report delivers:
• Revenues for the Global Blood Glucose Monitoring Device Market to 2026 – assess that overall world blood glucose monitoring device market’s potential and get forecasted revenues for the leading sub-classes: • Glucose Test Strips • Glucose Meters • Continuous Glucose Monitoring • Accessories
• National market forecasting to 2026 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and Rest of the World – explore the best regions for treatment demand, sales and growth
• Companies, news and opinions – examine major players in this market and their main products, including Roche, Johnson & Johnson, Sanofi and Medtronic among others.
• Two exclusive interviews with experts in this market: – Dr. Sara Bachmann, a senior physician at The Division of Endocrinology / Diabetology within the University Children’s Hospital in Basel, Switzerland. – Bennet Dunlap, co- founder Diabetes Patient Advocacy Coalition (DPAC) a patient advocacy group that helps individuals with diabetes effect change in their local communities.
• Analysis of what stimulates and restrains that industry and market – assess challenges and strengths there, helping you compete and gain advantages.
Main Questions Answered by This Analysis • How is the blood glucose monitoring device market evolving? • What is driving and restraining the blood glucose monitoring device market? • What are the market shares of the leading segments of the blood glucose monitoring devices market in 2015? • How will each blood glucose monitoring devices submarket grow over the forecast period and how much revenue will these submarkets account for in 2026? • How will the market shares for each blood glucose monitoring devices submarket develop from 2015-2026? • What is the value of the leading blood glucose monitoring devices segments in important regions of the world? • What will be the main driver of the overall market from 2015 to 2026? • Will leading national blood glucose monitoring devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the leading national markets change by 2026 and which country will lead the market in 2026? • How will the industry evolve during the period between 2016 and 2026?
Chapter Overviews – The Report’s Structure In summary, the chapters of this report cover the following topics:
Chapter 1 provides an overview of the main points of the report along with the research methods utilized by Visiongain
Chapter 2 defines diabetes, symptoms, treatments, patient demographics and the types of diabetes monitoring devices being used today. There is also a brief section on the information on what diabetes monitoring test can show and the applications where a diabetes monitoring device can be used.
Chapter 3 explores the state of the SMBG devices market in 2015 and its future growth with a discussion on market trends in this industry.
Chapter 4 describes the glucose test strips market and assesses the growth of this sector during the forecast period 2015-2026, including market trends.
Chapter 5 describes the glucose meter market and assesses the growth of this sector during the forecast period 2015-2026, including market trends.
Chapter 6 describes the continuous glucose monitoring (CGM) market and assesses the growth of this sector during the forecast period 2015-2026, including market trends.
Chapter 7 discusses the profiles of the leading companies involved in the SMBG devices market.
Chapter 8 discusses the regional market forecasts of SMBG devices in the US, Japan, France, Germany, UK, Spain, Italy, Russia, Brazil, China and India, during the period 2015-2026.
Chapter 9 identifies strengths, weaknesses, opportunities and threats facing the industry and market. The main drivers and restraints are also described, in addition to the current issues facing the SMBG devices market between 2015 and 2026.
Chapter 10 contains the transcript of Visiongain interview with Dr. Sara Bachmann, a senior physician at The Division of Endocrinology / Diabetology within the University Children’s Hospital in Basel, Switzerland. As well as Bennet Dunlap, co- founder Diabetes Patient Advocacy Coalition (DPAC) a patient advocacy group that helps individuals with diabetes effect change in their local communities.
Chapter 11 is a summary of the report, highlighting conclusions from our research and analyses
Who Is That Study For? Blood Glucose Monitoring Devices World Market Outlook 2016-2026: Glucose Test Strips, Self-Monitoring Blood Glucose Device, Non-Invasive Blood Glucose Meter, Continuous Blood Glucose Monitor will prove invaluable for anyone wanting to better understand the industry and its underlying dynamics. It will prove useful for businesses who wish to expand into different sectors or explore a new region for expansion of their existing operations. The report comprehensively lays out the market drivers, restraints, forecasts, technologies, investments, risks and trends to help the reader formulate a better-informed business strategy. This report will be ideal for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, Directors and others. Furthermore, governments, agencies and organisations will also find value in our research report.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Executive Summary 1.1 Sector Highlights 1.2 Blood Glucose Monitoring Market Segmentation 1.3 Overview of Findings 1.4 Chapter Outline 1.5 Aims, Scope and Format of the Report 1.6 Who is This Report For? 1.7 Methodology 1.8 Research and Analysis Methods 1.9 Frequently Asked Questions (FAQ) 1.10 Glossary of Terms Related to the Report 1.11 About Visiongain
2. Introduction to Diabetes and Monitoring Devices 2.1 What is Diabetes? 2.1.1 Classifying Diabetes 2.1.2 Symptoms And Long-Term Complications 2.1.3 Treatment 2.1.4 Diagnosis 2.1.5 Diabetes on the global and public agenda 2.2 Diabetes Monitoring 2.2.1 Glucose Levels 2.2.2 Reagent Strips and Glucose Meters 2.2.3 Urine Testing 2.2.4 Haemoglobin A1c Testing 2.2.5 Blood Pressure 2.2.6 Blood Cholesterol 2.2.7 Eye Tests
3. The Global Self Monitoring Blood Glucose Devices Market, 2015-2026 3.1 The Global Diabetes Care Devices Market, 2015 3.2 SMBG Devices Market, 2015 3.3 Global SMBG Devices Market Forecast, 2015-2026
4. Glucose Test Strips Market, 2016-2026 4.1 Glucose Test Strips 4.2 Glucose Test Strips: Market Forecast, 2015-2026 4.2.1 Glucose Test Strips: Industry Trends, 2016-2026 4.3 Companies and Products 4.3.1 Abbott Diabetes Care 4.3.2 Bayer Healthcare 4.3.3 Roche 4.3.4 LifeScan 4.3.5 Nipro Diagnostics
5. Glucose Meters Market, 2016-2026 5.1 Glucose Meters 5.1.1 How It Works 5.2 Marketed Glucose Meters 5.3 Glucose Meters: Market Forecast, 2015-2026 5.3.1 Technology Advancements 5.3.2 Growing Significance of Emerging Markets 5.3.3 Blood Glucose Meters of Particular Interest 5.3.4 Emergence of CGMs
6. Continuous Glucose Monitoring Market, 2016-2026 6.1 Continuous Glucose Monitoring (CGM) 6.2 Continuous Glucose Monitoring Market, 2015 6.3 Continuous Glucose Monitoring (CGM) Systems vs. Fingertip Testing 6.3.1 The CGM Pipeline 6.4 Continuous Glucose Monitoring: Market Forecast, 2015-2026 6.5 Continuous Glucose Monitoring: Industry Trends, 2016-2026 6.5.1 Improved Glucose Control 6.5.2 The US is the Largest Market for CGMs 6.5.3 Challenges to Growth of CGMs
7. Leading Companies in the SMBG Devices Market, 2015 7.1 Market Showing Signs of Recovery 7.2 SMBG Devices Market: Breakdown By Company, 2015 7.3 Roche 7.3.1 Sales and Recent Performance Analysis 7.3.2 Roche Diagnostics 7.3.3 Marketed Glucose Meters 7.4 Abbott Laboratories 7.4.1 Sales and Recent Performance Analysis 7.4.2 Abbott Geographic Sales 7.4.3 Marketed Glucose Meters 7.5.1 Sales and Recent Performance Analysis, 2015 7.5.1.1 Medical Devices And Diagnostics (MD&D) 7.5.2 J&J Geographic Sales 7.5.3 Marketed Glucose Meters 7.6 Bayer Healthcare 7.6.1 Sales and Recent Performance Analysis, 2015 7.6.2 Bayer Healthcare Geographic Sales 7.6.3 Marketed Glucose Meters 7.7 Other Companies
8. Leading National SMBG Devices Markets, 2015-2026 8.1 Regional Breakdown of The Global Diabetes Monitoring Devices Market, 2015 8.2 The Global SMBG Devices Market: Regional Forecast, 2015-2026 8.3 US Medical Device Market 8.3.1 The US Market Forecast: 2015-2026 8.4 The European Market 8.4.1 Changes in the New EU Medical Device Regulations 8.4.2 Post Marketing Surveillance in the EU 8.4.3 Germany 8.4.4 France 8.4.5 Italy 8.4.6 Spain 8.4.7 UK 8.5 The Japanese Market 8.6 The BRIC Market 8.6.1 The Chinese Market 8.6.1.1 New Policies Favouring Domestically-Made Medical Devices 8.6.2 The Indian Market 8.6.3 The Russian SMBG Market 8.6.3.1 Russian SMBG Market Forecast 2015-2026 8.6.4 Brazilian Market Forecast, 2015-2026 8.6.4.1 Brazilian Market Forecast, 2015-2026 8.6.4.2 The Brazillian Market
9. SWOT Analysis of the SMBG Devices Market, 2016 9.1 SMBG Devices: Industry Trends 9.2 Strengths 9.2.1 Effective Disease Management 9.2.2 Technological Advancements 9.2.3 Patient Demographics 9.3 Weaknesses 9.3.1 Regulatory Board Approvals 9.3.2 Benefits Vs. Costs 9.3.3 Reimbursement Issues 9.4 Opportunities 9.4.1 Globalisation: Established and Emerging Markets 9.4.2 Next-Generation Blood Glucose Monitoring 9.4.3 Mobile Applications 9.5 Threats 9.5.1 “Burnout”: Issues with Testing Adherence 9.5.2 Decreasing Investments
10. Opinions from Our Industry Survey 10.1 Interview with Bennet Dunlap of The Diabetes Patient Advocacy Coalition (DPAC) 10.2 The Diabetes Patient Advocacy Coalition (DPAC) 10.3 Patient Safety 10.4 Market Drivers 10.5 Use of Generic Products 10.6 The Future of Blood Glucose Monitoring 10.7 Interview with Dr. Sara Bachmann of the Endocrinology and Diabetology Department; University Children’s Hospital Basel 10.8 The Endocrinology and Diabetology Department; University Children’s Hospital Basel 10.9 Patient Safety 10.10 Market Drivers 10.11 Use of Generic Products 10.12 The Future of Blood Glucose Monitoring
11. Conclusions 11.1 Overview 11.2 Glucose Test Strips will Remain the Largest Segment 11.3 Prominent Companies in the Market 11.4 World Market Forecasts 11.5 Future Outlook and Concluding Remarks
Associated Reports Appendix A Appendix B
List of Figures Figure 1.1 Blood Glucose Monitoring Market Segmentation Figure 3.1 The Global Diabetes Care Devices Market: Net Sales ($bn), By Sector, 2015 Figure 3.2 The Global Diabetes Care Devices Market: Market Shares (%), By Sector, 2015 Figure 3.3 SMBG Devices Market: Net Sales ($bn), By Product, 2015 Figure 3.4 SMBG Devices Market: Market Shares (%), By Product, 2015 Figure 3.5 Global SMBG Devices Market ($bn), AGR (%), 2015-2020 Figure 3.6 Global SMBG Devices Market ($bn), AGR (%), 2021-2026 Figure 4.1 Anatomy of a Blood Glucose Test Strip Figure 4.2 Glucose Test Strips: Market Forecast ($bn), AGR(%), 2015-2020 Figure 4.3 Glucose Test Strips: Market Forecast ($bn), AGR (%), 2021-2026 Figure 5.1 Glucose Meters: Market Forecast ($bn), AGR (%), 2015-2020 Figure 5.2 Glucose Meters: Market Forecast ($bn), AGR (%), 2021-2026 Figure 5.3 Evolution of Blood Glucose Monitors Figure 6.1 CGM Market: Net Sales ($m) By Product, 2015 Figure 6.2 CGM Market: Market Shares (%) By Product, 2015 Figure 6.3 CGM Devices: Market Forecast ($bn), AGR (%), 2015-2020 Figure 6.4 CGM Devices: Market Forecast ($bn), AGR (%), 2021-2026 Figure 7.1 Leading Companies in the SMBG Devices Market: Net Sales ($bn), 2015 Figure 7.2 Leading Companies in the SMBG Devices Market: Market Shares (%), 2015 Figure 7.3 Roche: Net Sales ($bn) By Sector, 2015 Figure 7.4 Roche: Market Shares (%) By Sector, 2015 Figure 7.5 Roche Diagnostics: Net Sales ($bn) By Sector, 2015 Figure 7.6 Roche Diagnostics: Market Shares (%) By Sector, 2015 Figure 7.7 Roche Diagnostics: Net Sales ($bn) By Region, 2015 Figure 7.8 Roche Diagnostics: Market Shares (%) By Region, 2015 Figure 7.9 Abbott: Net Sales ($bn) By Sector, 2015 Figure 7.10 Abbott: Market Shares (%) By Sector, 2015 Figure 7.11 Abbott: Net Sales ($bn) By Region, 2015 Figure 7.12 Abbott: Market Shares (%) By Region, 2015 Figure 7.13 Johnson & Johnson: Net Sales ($bn) By Segment, 2015 Figure 7.14 Johnson & Johnson: Market Shares (%) By Segment, 2015 Figure 7.15 J&J Medical Devices: Net Sales ($bn) By Segment, 2015 Figure 7.16 J&J Medical Devices & Diagnostics: Market Shares (%) By Segment, 2015 Figure 7.17 J&J Medical Devices & Diagnostics: Net Sales ($bn) By Region, 2015 Figure 7.18 J&J Medical Devices & Diagnostics: Market Shares (%) By Region, 2015 Figure 7.19 Bayer Group: Net Sales ($bn) By Segment, 2015 Figure 7.20 Bayer Group: Market Shares (%) By Segment, 2015 Figure 7.21 Bayer Healthcare: Net Sales ($bn) By Region, 2015 Figure 7.22 Bayer Healthcare: Market Shares (%) By Region, 2015 Figure 8.1 SMBG Devices Market: Sales ($bn) By Country, 2015 Figure 8.2 SMBG Devices Market: Market Shares (%) By Country, 2015 Figure 8.3 The US SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.4 The European SMBG Devices Market: Net Sales ($bn) By Region, 2015 Figure 8.5 The European SMBG Devices Market: Market Shares (%) By Region, 2015 Figure 8.6 The European SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.7 German SMBG Devices Market: Forecast ($bn), AGR (%), 2015-2026 Figure 8.8 French SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.9 The Italian SMBG Devices Market Forecast ($bn), AGR (%) 2015-2026 Figure 8.10 The Spanish SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.11 UK SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.12 Japan SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.13 The Chinese SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.14 The Indian SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.15 The Russian SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 8.16 The Brazilian SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026 Figure 9.1 Google’s Next-Generation Non-invasive Blood Glucose Monitor Figure 9.2 Google’s Next-Generation Non-invasive Blood Glucose Monitor: How it works Figure 9.3 Diabetes Prevalence (%) in Leading National Markets, 2015 Figure 11.1 Projected SMBG Devices Market Growth Revenues ($bn), By Product Figure 11.2 Projected Total SMBG Devices Market Size ($bn) In 2015, 2020 and 2026
List of Tables Table 2.1 High Blood Glucose Age-Standardized Mortality Rates Per 100,000 (Age 20+) Table 3.1 The Global Diabetes Care Devices Market: Net Sales ($bn), By Sector, 2015 Table 3.2 SMBG Devices Market: Net Sales ($bn) and Market Shares (%), By Product, 2015 Table 3.3 Global SMBG Devices Market, By Technology: Revenue ($bn), AGR (%) and CAGR (%), 2015-2020 Table 3.4 Global SMBG Devices Market, By Technology: Revenue ($bn), AGR (%) and CAGR (%) 2021-2026 Table 4.1 Glucose Test Strips: Market Forecast ($bn), 2015-2020 Table 4.2 Glucose Test Strips: Market Forecast ($bn), 2021-2026 Table 5.1 Top Marketed Glucose Meters, 2016 Table 5.2 Glucose Meters: Market Forecast ($bn), AGR (%), CAGR (%) 2015-2020 Table 5.3 Glucose Meters: Market Forecast ($bn) ), AGR (%), CAGR (%), 2021-2026 Table 5.4 Blood Glucose Monitoring Devices of Particular Interest Table 6.1 CGM Market: Net Sales ($m) and Market Shares (%) By Product, 2015 Table 6.2 Advantages of CGMs over Fingerstick Testing Systems, 2016 Table 6.3 Marketed CGMs, 2016 Table 6.4 CGM Pipeline, 2016 Table 6.5 CGM Devices: Market Forecast ($bn), ), AGR (%), CAGR (%), 2015-2020 Table 6.6 CGM Devices: Market Forecast ($bn), ), AGR (%), CAGR (%), 2021-2026 Table 7.1 Leading Companies in the SMBG Devices Market: Net Sales ($bn) and Market Shares (%), 2015 Table 7.2 Roche: Net Sales ($bn) & Market Shares (%) By Sector, 2015 Table 7.3 Roche Diagnostics: Net Sales ($bn), Market Shares (%) By Sector, 2015 Table 7.4 Roche Diagnostics: Net Sales ($bn) and Market Shares (%) By Region, 2015 Table 7.5 Roche Diagnostics Glucose Meters, 2016 Table 7.6 Abbott: Net Sales ($bn), Market Shares (%) By Sector, 2015 Table 7.7 Abbott: Net Sales ($bn) and Market Shares (%) By Region, 2015 Table 7.8 Johnson & Johnson: Net Sales ($bn) & Market Shares (%) By Segment, 2015 Table 7.9 J&J Medical Devices: Net Sales ($bn) & Market Shares (%) By Franchise, 2015 Table 7.10 J&J Medical Devices & Diagnostics: Net Sales ($bn) & Market Shares (%) By Region, 2015 Table 7.11 LifeScan Glucose Meters, 2015 Table 7.12 Bayer Group: Net Sales ($bn) & Market Shares (%) By Segment, 2015 Table 7.13 Bayer Healthcare: Net Sales ($bn) & Market Shares (%) By Region, 2015 Table 7.16 Bayer Healthcare Glucose Meters, 2015 Table 7.17 Other Companies Operating in The Diabetes Monitoring Devices Market, 2015 Table 7.17 (contd.) Other Companies Operating in The Diabetes Monitoring Devices Market, 2015 Table 8.1 SMBG Devices Market: Sales ($bn) and Market Shares (%) By Country/Region, 2015 Table 8.2 SMBG Devices Market: Market Forecast ($bn) ), AGR (%), CAGR (%), Market Share (%), By Country/Region 2015-2026 Table 8.3 The Leading European SMBG Devices Markets: Market Value ($bn), European Market Shares (%) and Global Market Shares (%) By Region, 2015 Table 8.4 The European SMBG Devices Market Forecast By Region: Revenue ($bn), AGR (%), CAGR (%), 2015-2026 Table 8.5 German SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 8.6 France SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 8.7 Italy SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 8.8 Spain SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 8.9 UK SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 8.10 Japan SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 8.11 BRIC SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Market Share of BRIC Region (%), 2015-2026 Table 8.12 China SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026 Table 8.13 India SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026 Table 8.14 Russia SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026 Table 8.15 Brazil SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026 Table 9.1 SWOT Analysis of the Global SMBG Devices Market, 2015-2026 Table 9.2 Diabetes Prevalence (m) in Leading National Markets, 2015 Table 9.3 Classification of Medical Devices in the United States Table 11.1 SMBG Devices Market Forecast ($bn), AGR (%), CAGR (%), By Product, 2015, 2020 and 2026
Abbott Abbott Diabetes Care Abbott Nutrition AgaMatrix Alere All Medicus Animas Corporation Animas Corporation Animas Corporation (Acquired by J&J) Arkray Bayer Bionime BioRad Laboratories Boots Braun C8 MediSensors Calibra Medical (acquired by J&J) Cellnovo Debiotech Dexcom Dexcom Disetronic (Subsidiary of Roche) Echo Therapeutics EyeSense Genesis Health Technologies Hainice Medical HoMedics Johnson & Johnson Johnson & Johnson Medical Limited Lifescan Livongo Health Medingo (acquired by Roche) Medtronic Medtronic Medtronic Medtronic Diabetes Mellitor Nipro Diagnostics Nova Biomedical Omnis Health Omron Philosys Positive ID Prodigy Diabetes Care Roche Sanofi Sensors for Medicine and Science Siemens Healthcare Tandem Diabetes Care Verily Walmart Wockhardt
Other Organisations Mentioned American Medical Devices and Diagnostic Association (AMDD) China Food and Drug Administration (CFDA) China’s National Health and Planning Commission (NHPC) Endocrinology and Diabetology Department, University Children’s Hospital, Basel Medical Devices Information & Technology Assistance Centre (MDITAC) Medicines and Healthcare products Regulatory Agency (MHRA) National Competent Authorities (NCAs) National Diabetes Education Program (NDEP) National Institute for Health and Clinical Excellence (NICE) National Medical Devices Authority (NMDA) NHS England Pharmaceuticals and Medical Devices Agency (PMDA) Technology Evaluation Centers (TEC) The Diabetes Patient Advocacy Coalition United States Food and Drug Administration (FDA) US Department of Health and Human Services World Bank World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Blood Glucose Monitoring Devices World Market Outlook 2016-2026
Download sample pages
Complete the form below to download your free sample pages for Blood Glucose Monitoring Devices World Market Outlook 2016-2026
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
